Delivery Order SPE2DB20D3101-SPE2DB22FJ3J9
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of VASCEPA 1 GM CAPSULE 120S, a cardiovascular medication. The $7,777.43 firm fixed-price delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen Drug Corp holds with the DLA Troop Support Medical. This IDC serves as the primary vehicle for the company to provide a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Vascepa 1 GM Capsule 120S. The contract, valued at $27,009.35, is a delivery order under a larger Indefinite Delivery Contract (IDC) with Amerisourcebergen's parent company, Cencora, Inc., which has a ceiling value of $999,999,999.00 and runs through November 2026. This IDC serves as a primary vehicle for Cencora, Inc. to provide a...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,619.58 firm fixed-price delivery order is for the supply of Vascepa 1 GM capsules. This award is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen's parent company, Cencora, Inc., holds with the DLA Troop Support Medical through November 2026. This IDC serves as the primary vehicle for...
- This federal contract award is a $1,683.46 delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Vascepa 1 GM capsules, a cardiovascular medication. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $3,755.84 firm fixed-price delivery order is for the supply of VASCEPA 1 GM CAPSULE 120S, a cardiovascular medication. The contract has a completion date of December 6, 2022 and was awarded on December 5, 2022. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,701.49 Firm Fixed Price delivery order is for the supply of VASCEPA 1 GM CAPSULE 120S, a cardiovascular medication. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a comprehensive vehicle for providing a...
- This federal contract award is for the delivery of VASCEPA 1 GM CAPSULE 120S, a pharmaceutical product, by Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $3,030.72 firm-fixed-price contract was awarded by the Defense Logistics Agency (DLA), a defense agency, on September 27, 2021, with a completion date of September 28, 2021. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) between Cencora, Inc. (doing business as Amerisourcebergen) and the...
- This federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., is for the delivery of Vascepa 1 GM Capsule 120S, a prescription medication. The $17,517.47 Firm Fixed Price contract has an ultimate completion date of October 25, 2021. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a wide...
- This federal contract award is for the delivery of Vascepa 1 GM capsules to the Defense Logistics Agency (DLA) for a total ceiling value of $13,399.15. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on January 31, 2023, with a completion date of February 1, 2023. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. This IDC,...
- This federal contract award, valued at $1,431.07, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp. The contract is for the delivery of VASCEPA 1 GM CAPSULE 120S, a pharmaceutical product. This appears to be a firm-fixed-price delivery order contract with a completion date of May 12, 2023. The contract was not set aside for any specific business type. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that has a...
- SPE2DB20D3101Indefinite Delivery Contract
- SPE2DB20D3101-SPE2DB22FJ3J9Delivery Order
This federal contract award, valued at $4,567.30, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of VASCEPA 1 GM CAPSULE 120S, a cardiovascular medication. This is a delivery order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. The IDC, valued at up to $999,999,999.00, serves as the primary vehicle for Cencora, Inc. to provide a comprehensive range of pharmaceutical products and medical supplies to support military and veteran healthcare programs globally. The contract award does not have a set-aside designation, indicating open competition. This delivery order is part of Amerisourcebergen's broader role as a critical supplier of essential medical commodities to various federal agencies, including the Department of Defense and Department of Veterans Affairs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.6k | 3/31/22 |